T0	Participants 80 143	patients with hematuria related to benign prostate hyperplasia.
T1	Participants 319 391	patients with hematuria secondary to benign prostatic hyperplasia (BPH).
T2	Participants 414 461	30 patients who were candidates for BPH surgery
T3	Participants 504 596	All patients had history of gross hematuria and evaluated by ultrasonography and cystoscopy.